Comparison of the effect of low dose Megestrol (40 mg) and Medroxyprogesterone 10 mg on the quality of life in menopausal women.
Phase 3
- Conditions
- Menopause symptoms.Menopausal and other perimenopausal disorders
- Registration Number
- IRCT20230930059567N1
- Lead Sponsor
- Karaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Iranian women aged 45 to 55 year?.
FSH serum level greater than or equal to 40-20 mm units per milliliter (pre menopausal)
Do not have a physical or mental illness .
Do not have addiction or use of hookah cigarettes or alcohol.
The person's body mass index should be less than or equal to 29.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life score in menqol questionnaire. Timepoint: Measuring the quality of life during the study and 1 month after Megestrol consumption. Method of measurement: Menopausal Women's Quality of Life Questionnaire - Persian version (Menqol).;Quality of life score in menqol questionnaire. Timepoint: Measuring the quality of life during the study and 1 month after Medroxyprogestrone consumption. Method of measurement: Menopausal Women's Quality of Life Questionnaire - Persian version (Menqol).
- Secondary Outcome Measures
Name Time Method